Abstract:Integrin aVb3 is a prominent member of the "RGD-recognizing" integrin family of cell surface receptors. aVb3 binds to various extracellular matrix (ECM) proteins and oxysterols such as 25-hydroxycholesterol, is implicated in several diseases, including cancer metastasis, lung fibrosis, inflammation, and autoimmune diseases, and is pursued as a valuable therapeutic target. Despite enormous efforts to seek a pure antagonist, to date, no single drug candidate has successfully reached clinics due to associated partial agonism and toxicity issues. Developing effective and safe inhibitors require a thorough understanding of the molecular interactions and structural changes related to the receptor's activation and inhibition mechanisms. This study offers a comprehensive residue-residue contact and network analyses of the ligand-binding beta-propeller alpha-I domains (headpiece) based on all available experimental structures of integrin aVb3 in unliganded, agonist-, antagonist-, and antibody-bound states. The analyses reveal many critical interactions that were not reported before and show that specific orientation and interactions of residues from the specificity-determining loop (SDL) are critical in molecular recognition and regulation. Also, the network analysis reveals that residues from the nearby allosteric site (site II) connect to the primary RGD-binding site via SDL, which likely acts as an interface between the two sites. Our results provide valuable insights into molecular interactions, structural changes, distinct features of the active and inactive headpiece conformations, the role of SDL in ligand recognition, and SDL-mediated allostery. Thus, the insights from this study may facilitate the designing of pure antagonists or site II-mediated allosteric modulators to integrin aVb3 to treat various diseases.

N-Glycosylation of the I-like Domain of β1 Integrin Is Essential for β1 Integrin Expression and Biological Function

N-Glycosylation of Integrin Α5 Acts As a Switch for EGFR-mediated Complex Formation of Integrin Α5β1 to Α6β4

Role of Site-Specific Glycosylation in the I-Like Domain of Integrin β1 in Small Extracellular Vesicle-Mediated Malignant Behavior and FAK Activation

Regulation on the expression and N-glycosylation of integrins by N-acetylglucosaminyltransferase V.

Big1, A Brefeldin A-Inhibited Guanine Nucleotide-Exchanae Protein, Is Required For Correct Glycosylation And Function Of Integrin Beta 1

Distinct Functions of Integrin Alpha and Beta Subunit Cytoplasmic Domains in Cell Spreading and Formation of Focal Adhesions.

Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor

Heterodimerization of Integrin Mac-1 Subunits Studied by Single-Molecule Imaging.

Increase in β1-6 GlcNAc branching caused by N- acetylglucosaminyltransferase V directs integrin β1 stability in human hepatocellular carcinoma cell line SMMC-7721

BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin β1

Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling.

N-glycosylation of the β2 adrenergic receptor regulates receptor function by modulating dimerization

Role Ofn-Linked Glycosylation in Biosynthesis, Trafficking, and Function of the Human Glucagon-Like Peptide 1 Receptor

The Role of N‐glycosylation in the Stability, Trafficking and GABA‐uptake of GABA‐transporter 1

Importance of N-linked Glycosylation in the Functional Expression of Murine CD1d1.

Relating Conformation to Function in Integrin Α5β1.

Focal-adhesion kinase regulates the sialylation of N-glycans via the PI4KIIα-PI4P pathway

N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis

Regulation of integrin alphaIIbbeta3 activation by distinct regions of its cytoplasmic tails.

Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL)

Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model.